Collecting Evidence for Improved Healthcare Outcomes
One of the key steps in improving healthcare outcomes is to collect evidence of the effectiveness of our interventions and how they lead to savings on downstream costs. This is where MRI plays a crucial role in providing population-scale data. By continuously gathering evidence, we can work towards making MRI a covered service for all consumers.
It is important for consumers to advocate for the inclusion of MRI as a covered service, based on its positive impact on health outcomes. By voicing their support, consumers can drive change within the healthcare system and ensure that essential services like MRI are accessible to all.
Early Cancer Diagnosis and Improved Patient Outcomes
When it comes to cancer diagnosis, early detection is key to improving patient outcomes. While some small cancers may resolve on their own, most cancers that are detected through imaging are already at least a centimeter in size. The majority of cancers discovered through MRI are localized and in early stages, typically stage one or two. This early diagnosis is crucial for improving patient outcomes and increasing the chances of successful treatment.
In comparison to the UK health system, where the average stage of cancer diagnosis is early stage three, the use of MRI at Prenuvo has led to significant time savings and better outcomes for patients.
As more cancers are diagnosed early, new strategies for managing patients are being developed. For example, men with prostate cancer may opt for “watchful waiting”, where regular imaging is used to monitor the progression of the disease. Early diagnosis not only improves patient outcomes but also drives innovation in downstream care management.
Overall, the use of MRI for early cancer detection has the potential to revolutionize healthcare by improving outcomes, reducing costs, and promoting innovation in patient care.
